Study on Psychological Treatments for Youth with Disruptive Mood Dysregulation Disorder
This clinical trial addresses a critical gap in the treatment of Disruptive Mood Dysregulation Disorder (DMDD) in youth, which could lead to new therapeutic protocols. The outcomes may influence treatment guidelines and create opportunities for further research and funding in the mental health sector.
Phase III
Psychiatry / Disruptive Mood Dysregulation Disorder
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
This clinical trial addresses a critical gap in the treatment of Disruptive Mood Dysregulation Disorder (DMDD) in youth, which could lead to new therapeutic protocols. The outcomes may influence treatment guidelines and create opportunities for further research and funding in the mental health sector.
Why it matters
This clinical trial addresses a critical gap in the treatment of Disruptive Mood Dysregulation Disorder (DMDD) in youth, which could lead to new therapeutic protocols. The outcomes may influence treatment guidelines and create opportunities for further research and funding in the mental health sector.
What changed
Trial Update
Analysis
A clinical trial is underway to evaluate the efficacy of Cognitive Behavioral Therapy and Interpretation Bias Training for children aged 8-17 with DMDD.
This clinical trial addresses a critical gap in the treatment of Disruptive Mood Dysregulation Disorder (DMDD) in youth, which could lead to new therapeutic protocols. The outcomes may influence treatment guidelines and create opportunities for further research and funding in the mental health sector.
Monitor trial outcomes, participant feedback, and any subsequent publications or treatment guidelines that emerge from this research.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.